England's Antidepressant Surge Linked to Poverty & Pandemic

A recent NHS report indicates that approximately one in seven people in England were prescribed an antidepressant in 2025-26, marking a record high. Media reports have raised concerns, often attributing this trend to 'overprescribing' by general practitioners.

However, this perspective overlooks the significant correlation between rising antidepressant use and increased diagnoses of depression and anxiety. The aftermath of the COVID-19 pandemic, which doubled the rate of depressive symptoms in adults, is a major contributing factor. Data shows that as of April 2025, these rates remain elevated, particularly affecting young people.

Furthermore, persistent regional inequalities demonstrably worsen mental health outcomes, directly impacting antidepressant prescription rates. The most impoverished areas of England exhibit the most dramatic increases, with one integrated care board showing 200 in every 1,000 people on medication, reflecting a clear link between poverty, chronic stress, and poorer mental health.

While talking therapies are recommended for less severe depression, lengthy waiting lists on the NHS, often months or years, make them inaccessible for many, especially in deprived areas. Antidepressants, by contrast, are generally accessible. GPs adhere to strict National Institute for Health and Care Excellence guidelines, prescribing medication as a response to legitimate patient demand and preference, not as a default first-line treatment for mild cases.

The government has introduced a new mental health strategy aiming for preventive care and exploring technological interventions. Despite ongoing efforts to reform mental health services, the current record rates of antidepressant use highlight genuine need, stemming from deeper social and economic crises rather than physician overreach.